CONOR MEDSYSTEMS INC 4
4 · CONOR MEDSYSTEMS INC · Filed Dec 21, 2004
Insider Transaction Report
Form 4
Gentile Frank T
Director
Transactions
- Conversion
Common Stock
2004-12-17+618,799→ 618,799 total(indirect: Held by H&Q Life Sciences Investors) - Conversion
Series D Preferred Stock
2004-12-17−559,999→ 0 total(indirect: Held by H&Q LIfe Sciences Investors)From: 2004-12-17→ Common Stock (559,999 underlying) - Conversion
Series E Preferred Stock
2004-12-17−109,200→ 0 total(indirect: Held by H&Q Healthcare Investors)From: 2004-12-17→ Common Stock (109,200 underlying) - Conversion
Series D Preferred Stock
2004-12-17−840,000→ 0 total(indirect: Held by H&Q Healthcare Investors)From: 2004-12-17→ Common Stock (840,000 underlying) - Conversion
Common Stock
2004-12-17+949,200→ 949,200 total(indirect: Held by H&Q Healthcare Investors) - Conversion
Series E Preferred Stock
2004-12-17−58,800→ 0 total(indirect: Held by H&Q LIfe Sciences Investors)From: 2004-12-17→ Common Stock (58,800 underlying)
Footnotes (3)
- [F1]The Issuer's Preferred Stock automatically converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering.
- [F2]The shares are held by H&Q Healthcare Investors. Hambrecht and Quist Capital Management, LLC is the Advisor of H&Q Healthcare Investors. The Reporting Person is Vice President, Research, of Hambrecht and Quist Capital Management, LLC
- [F3]The shares are held by H&Q Life Science Investors. Hambrecht and Quist Capital Management, LLC is the Advisor of H&Q Life Science Investors. The Reporting Person is Vice President, Research, of Hambrecht and Quist Capital Management, LLC